Letter to the editor from Pant et al

Código QR

Letter to the editor from Pant et al

Guardado en:

Detalles Bibliográficos
Autores principales:	Aung Naing, Shubham Pant, Justin T Moyers
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/0d4cb06ba1b8494aa2cbca924975c68c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Reply to Rizzo et al.
por: Arndt Vogel, et al.
Publicado: (2021)

Editoral
por: Luiz Claudio Santos Thuler
Publicado: (2005)

Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
por: Niamh Coleman, et al.
Publicado: (2021)

Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia [Response To Letter]
por: Asmare Adella G
Publicado: (2021)

Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality
por: Ioannis A. Vathiotis, et al.
Publicado: (2021)

DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer
por: Rish K Pai, et al.
Publicado: (2021)

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
por: Barbara Savoldo, et al.
Publicado: (2021)

Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB
por: Arumugam Nagalingam, et al.
Publicado: (2021)

Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
por: Jing Yang, et al.
Publicado: (2021)

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
por: Costanza Paoletti, et al.
Publicado: (2021)

4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells
por: Frederick L Locke, et al.
Publicado: (2021)

Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy
por: Chun-Yu Chen, et al.
Publicado: (2021)

Microbiome dysbiosis in lung cancer: from composition to therapy
por: Ning-Ning Liu, et al.
Publicado: (2020)

Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA
por: Justin D. Finkle, et al.
Publicado: (2021)

Endothelial cell malignancies: new insights from the laboratory and clinic
por: Michael J. Wagner, et al.
Publicado: (2017)

Correction: Pan et al. Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer. <i>Cancers</i> 2020, <i>12</i>, 94
por: Mei-Ren Pan, et al.
Publicado: (2021)

Management of early breast cancer in older women: from screening to treatment
por: Elomrani F, et al.
Publicado: (2015)

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Julia Foldi, et al.
Publicado: (2021)

Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia
por: Brian S. White, et al.
Publicado: (2021)

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
por: Laura Pizzuti, et al.
Publicado: (2021)

Correction: Welter et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. <i>Cancers</i> 2021, <i>13</i>, 5016
por: Nils Welter, et al.
Publicado: (2021)

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study
por: Na Li, et al.
Publicado: (2021)

Prostate Cancer in Lebanon: Incidence, Temporal Trends, and Comparison to Countries From Different Regions in the World
por: Najla A. Lakkis, et al.
Publicado: (2021)

Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer
por: Federica Miglietta, et al.
Publicado: (2021)

Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy
por: Aphinives P, et al.
Publicado: (2014)

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study
por: Helen Y Chu, et al.
Publicado: (2021)

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
por: Khalid El Bairi, et al.
Publicado: (2021)

Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer
por: Fabio Puglisi, et al.
Publicado: (2021)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Sasha E. Stanton, et al.
Publicado: (2021)

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
por: Fenil Shah, et al.
Publicado: (2017)

Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
por: Olga Martínez-Sáez, et al.
Publicado: (2021)

Establishment and characterization of a receptor-negative, hormone-nonresponsive breast cancer cell line from an Iraqi patient
por: Al-Shammari AM, et al.
Publicado: (2015)

Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort
por: Xavier Pivot, et al.
Publicado: (2017)

Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. <i>Cancers</i> 2021, <i>13</i>, 3814
por: Markus Notter, et al.
Publicado: (2021)

Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
por: Apostolia Maria Tsimberidou, et al.
Publicado: (2021)

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
por: C. B. Westphalen, et al.
Publicado: (2021)

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
por: Yongxian Zhuang, et al.
Publicado: (2021)

Need for specialized neuro-oncology units in low- and middle-income countries: Lessons learned from the COVID-19 pandemic
por: Jhoan Sebastián Robledo-Arias, et al.
Publicado: (2021)

Collagen fiber orientation disorder from H&E images is prognostic for early stage breast cancer: clinical trial validation
por: Haojia Li, et al.
Publicado: (2021)

Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates
por: Daniel Y. Joh, et al.
Publicado: (2021)